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Background: There is scarce or no data on prevalence and presentation of acute coronary 
  syndrome (ACS) among women of reproductive age. Furthermore, whether women of 
reproductive age presenting with ACS have the same risk factors as men and older women is 
not known.
Objective: To analyze factors associated with ACS in women of reproductive age in comparison 
with older women and men of a similar age group.
Methodology: A total of 9702 cases of acute coronary syndrome over a 3-year period 
  (2006–2008) from the National Cardiovascular Disease database were analyzed, with focus on 
women of reproductive age (20–,40 years), looking into association with ethnicity,   comorbid 
illness, and the ACS stratum. Comparison with older women (40–,60 years; Control 1) 
and men of similar age group (Control 2) was made and analyzed using Fisher’s exact test and 
chi-square test when necessary.
Results: From a total of 9702 cases, 2344 (24.2%) were women. Of these, 45 (1.9%) were 
women between 20 and ,40 years, which is significantly lower than the two controls (older 
women 30.8%, and men of same age 6.2%, respectively; P , 0.0001). The distribution of 
ethnicity shows a similar pattern between the study group and the controls, but patients of Indian 
ethnicity were over-represented when compared with the Malaysian demographics of general 
population (31.3% versus 7.1%; P , 0.0001). ACS in women of reproductive age was associated 
with diabetes mellitus in 37.8%, hypertension in 40.0%, and dyslipidemia in 24.4% of cases, 
similar to men of the same age but significantly lower than the older women (P , 0.0001). 
Smoking is not a major risk factor in the study group, where only 6.7% ever smoked, similar to 
older women (6.8%, P = 1.000) and significantly much less compared with men of the same age 
(84.1%; P , 0.0001). Regarding the ACS stratum, a significantly higher percentage of women 
in the study group had ST-segment elevation myocardial infarction compared with older women 
(P = 0.0085) but less than that of men of similar age (P = 0.0187).
Conclusion: ACS is rare in women of reproductive age. Diabetes, hypertension, and Indian 
ethnicity were identified as important contributors.
Keywords: reproductive-aged women, comorbidities, risk factors
Background
Even though coronary heart disease is the leading cause of death for both men and 
women, there is scarce or no data on the prevalence and presentation of acute coronary 
syndrome (ACS) among women of reproductive age. Furthermore, whether women of 
reproductive age presenting with ACS have the same risk factors from men and older 
women is not known. The lack of data is probably due to the perceived low incidence International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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of ACS in this group of women and that it does not constitute 
a major health concern.
Incidence of ACS in women of reproductive age has 
indeed been reported to be low. Data from a Danish cohort 
reported an incidence of 25 per 100,000 person years while 
American data reported 57 per 100 000 person years.1,2 
The high circulating estrogen in younger women has 
traditionally been thought to be cardio-protective. However, 
with the increasing prevalence of certain cardiovascular risk 
factors, particularly obesity,3 the risk of ACS in younger-aged 
women is expected to rise and become a significant health 
concern in future. Furthermore, the use of oral contraceptive 
pills in reproductive-aged women has been shown to double 
the risk of ACS.4 There is also the risk of pregnancy, and 
while pregnancy itself has not usually been thought to be a 
risk factor for ACS, there is an increased level of estrogen 
and progesterone in maternal circulation which increases the 
risk of thrombosis, which may compound other pre-existing 
risk factors, leading to an increased ACS risk.
Data regarding ACS among men and older women are 
more established. Among the risk factors identified for ACS 
in this group are hypercholesterolemia, hypertension,   diabetes 
mellitus, family history of coronary artery   disease (CAD), 
and cigarette smoking. For younger adults,   especially women, 
it has been suggested that the risk factor profile for ACS is 
different. While hypercholesterolemia, family history of 
CAD, and maybe cigarette smoking may be similar, systemic 
hypertension and diabetes mellitus may not be very prevalent 
in younger adults.5,6 As for the role of gender in ACS, it has 
been found that while women overall had a lower incidence 
of ACS than men, and higher   prevalence of unstable angina 
rather than myocardial infarction, when myocardial infarction 
occurs in younger women, the   mortality and morbidity rates 
are higher than men of the same age.7,8
Based on these concerns, we feel it is important to 
increase our understanding regarding ACS in younger 
women, particularly those in the reproductive aged group. 
We aim to identify the specific risk factors for this group, 
and the information obtained can be helpful in planning 
management strategy in these women.
Methodology
This is a retrospective analysis of all cases of ACS recorded 
in the National Cardiovascular Disease Registry (NCVD). 
The registry was drawn up by content experts in the   discipline 
led by representatives from the Departments of Cardiology 
belonging to the Ministry of Health, universities, the 
National Heart Institute (Institut Jantung Negara (IJN)), and 
the Department of Medicine at Kuala Lumpur   Hospital. It 
was designed to be compatible with international registries 
and to   comply with guidelines issued by the Australia’s 
National Data   Elements for ACS, the Cardiology Audit and 
Registration Data Standards (CARDS), and the American 
  College of Cardiology Clinical Data Standards. The full 
version was designed to collect detailed demographic, 
past medical history, clinical and procedural information, 
and pharmacotherapy. In-patient, 30-days and 12-months 
follow-up forms were included to document the progress of 
the patient, in particular the occurrence of any major adverse 
cardiovascular events following discharge from hospital. 
A full list of participating sites may be found at the end of 
the article.
Patient enrolment
The registry records any patient aged 18 years and above who 
is diagnosed with ACS including ST-elevation myocardial 
infarction (STEMI), non-STEMI, and unstable angina 
admitted to the participating centers. ACS is defined as 
the presence of at least two of the following: 1) clinical 
presentation, 2) electrocardiographic changes, and 3) 
cardiac enzyme elevation. Typical clinical presentation is 
defined as: typical anginal pain at rest lasting more than 
20 minutes; new-onset angina of at least Canadian Cardio-
vascular Society grade III severity; previously diagnosed 
angina that has become more frequent, longer in duration, 
or more easily provoked; and/or acute decompensated heart 
failure in a patient with known ischemic heart disease. Typi-
cal electrocardiographic changes is defined as: ST-segment 
depression by more than 0.05 mV in two or more contiguous 
leads, marked symmetrical T-wave inversion by more than 
0.2 mV in the precordial leads, new bundle branch block, 
and/or sustained ventricular tachycardia. Typical pattern of 
elevation of conventional cardiac enzymes includes creatine 
kinase (CK), aspartate transaminase (AST), and lactate dehy-
drogenase (LDH), elevated Troponin T or I, and/or elevated 
isoenzyme CK-MB.
After discharge, the patient will have been contacted 
by telephone or seen in the clinic after 30 days and after 
12 months. For the purpose of the registry, any new   episodes 
of chest pain or diagnosis of ACS within 30 days of   discharge 
are considered recurrent episodes or complications of the 
index event. Symptoms that occur more than 30 days later 
are considered new episodes in which new event notification 
forms are submitted. The Medical Research and Ethics 
Committee waived informed consent for this national 
registry.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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A total of 9702 cases of acute coronary syndrome over 
a 3-year period (2006–2008) from the NCVD database 
were analyzed, with focus on the women of reproductive 
age (taken as women aged 20–,40 years). There were two 
control groups for this analysis: Control 1 was the older aged 
women (40–,60 years old), where we intended to look at 
the influence of hormonal status in the development of ACS; 
and Control 2 was the same-aged men, to look into gender 
differences.
As Malaysia is a pluralistic society, we looked into the 
association of ACS with ethnicity, focusing on the three 
major ethnic groups in Malaysia, ie, Malay, Chinese, and 
Indian. Each ethnic group has its own ethnocultural identity, 
and we hypothesize these differences may have significant 
contribution towards developing ACS.
We studied the comorbid illness commonly associated 
with ACS and compared their presence in the three groups, 
looking for a particular trend specific to reproductive-
aged women. We also looked into the ACS stratum to 
  identify specific patterns of clinical presentation in our 
focus group.
For all the factors identified, comparisons with older 
women (40–,60 years) and men of similar age were made 
and analyzed with Fisher’s exact test and chi-square test, 
when necessary, using SPSS software (version 17; SPSS 
Inc., Chicago, IL). Level of significance was determined at 
P , 0.05 at 95% confidence interval (CI).
Results
Over the 3-year period, 9702 cases of ACS were recovered 
from the registry. A total of 7358 (75.8%) were men, and 
2344 (24.2%) were women. Of these, 45 were from the 
reproductive-age group, which is 1.9% of all women or 0.5% 
overall. Older women (Control 1) recorded 721 cases (30.8% 
of all women or 7.4% overall), while men of the same age 
(Control 2) recorded 454 cases (6.2% of all men, or 4.7%), 
both of which are significantly higher than the study group.
The distribution of ethnicity shows no significant 
differences between the study group and the two   control 
groups (P . 0.05). From the results, it seemed that the 
  percentage of patients from Indian ethnicity were significantly 
higher in all three groups when compared with the M  alaysian 
demographics of general population (31.1%, 33.0%, and 
25.3% versus 7.1%; P , 0.0001). Unfortunately the s  tatistics 
for ethnic Indians from the specific age groups were not avail-
able for more direct comparison, and hence the significance 
of this finding cannot be determined.9 The results are shown 
in Table 1.
The prevalence of diabetes mellitus, hypertension, and 
dyslipidemia in women of reproductive age with ACS was 
similar to men of the same age but significantly lower than 
the older women (P , 0.0001). Smoking is not a major risk 
factor in the study group, where only 6.7% ever smoked, 
similar to older women (6.8%; P = 1.000) and significantly 
much less compared with men of the same age (84.1%; 
P , 0.0001). With regards to the family history, the 
prevalence did not   differ significantly between the study 
and the two control groups (P . 0.05). These findings are 
summarized in Table 2.
Regarding the ACS stratum, interestingly we found the 
study group to be more likely to have STEMI rather than 
  non-STEMI or unstable angina (51.1% versus 20.0% and 
28.9%, respectively). Significantly more women in the study 
group had STEMI compared with older women (P = 0.0085) 
but less than that of men of similar age (P = 0.0187), 
as shown in Table 3.
Table 1 Distribution of events of acute coronary syndrome and 
ethnicity
Ethnicity Study 
n = 45
Control 1 
n = 721
Control 2 
n = 454
Malay  
(%)
18 
(40.0)
347 
(48.1)
211 
(46.5)
chinese 
(%)
10 
(22.2)
105 
(14.6)
74 
(16.3)
Indian 
(%)
14 
(31.1)
238 
(33.0)
115 
(25.3)
Other 
(%)
3 
(6.7)
24 
(3.3)
43 
(9.5)
Missing 
(%)
0 7 
(1.0)
11 
(2.4)
Table 2 The prevalence of comorbid illnesses in acute coronary 
syndrome groups
Comorbidity Study 
n = 45
Control 1 
n = 721
P value Control 2 
n = 454
P value
Diabetes  
mellitus 
(%)
14 
(37.8)
440 
(61.0)
,0.0001 101 
(22.2)
.0.05
Hypertension 
(%)
18 
(40.0)
538 
(74.6)
146 
(32.1)
Dyslipidemia 
(%)
11 
(24.4)
256 
(35.5)
100 
(22.0)
smoking
    never 
(%)
42 
(93.3)
639 
(88.6)
1.000 54 
(11.9)
,0.0001
    ever 
(%)
3 
(6.7)
49 
(6.8)
382 
(84.1)
Family history 
(%)
7 
(15.6)
106 
(14.7)
.0.05 101 
(22.2)
.0.05International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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Discussion
Our study highlighted the following points: ACS is rare in 
women of reproductive age; comorbid illnesses and Indian 
ethnicity were potentially important contributors; and due to 
higher rate of STEMI, mortality risk is higher.
Our findings concur with the available data that ACS in 
reproductive-aged women is rare, and among the most likely 
reason is the protective effect of high   levels of circulating 
estrogen in this group of women. The   cardio-protective 
  mechanisms of estrogen can be exerted via   vasodilatation, 
vascular remodeling, angiogenesis, endothelial cell 
proliferation, hemostatic and thrombolytic functions, 
lipid metabolism, and antioxidant effects.10 Losordo et al 
  demonstrated significant association between estrogen 
receptor expression and absence of atherosclerosis in 
premenopausal women. In 12 normal arteries, estrogen 
receptor expression was shown immunohistochemically in 
10 (83.3%), whereas in 5 of 6 atherosclerotic arteries, no 
evidence of estrogen receptor expression was observed.11 
Older women with lower estrogen levels and men who do not 
enjoy similar cardioprotection recorded significantly higher 
incidence of ACS on our analysis.
In regards to risk factors for ACS, we found ethnic 
origin appeared to be important where patients of Indian 
ethnicity seemed particularly at risk, even at a younger age. 
The INTERHEART investigators in a detailed analysis 
of 15,152 cases and 14,820 age-matched controls from 
52   countries found the incidence of ACS in South Asian 
people to be higher than average and they also tend to 
  present earlier. The incidence of ACS in South Asian women 
aged ,40 years was found to be 3.9%, higher than the 2.3% 
average in that study and the 0.5% from our study. While it 
seemed that South Asian ethnicity is an absolute risk factor, 
further analysis revealed that people of South Asia had higher 
levels of ACS risk factors compared with the participants 
from the rest of the world, particularly a higher burden of 
metabolic risk factors, a higher prevalence of tobacco use, 
and lower rates of protective factors (physical activity, daily 
intake of fruits and vegetables),12,13 suggesting that those risk 
factors, and not ethnicity per se, is primarily responsible for 
their higher rates of ACS.
We think this suggestion could be applicable to 
our patients as well. While the NCVD Registry did not 
specifically provide data on risk factors for each ethnic group, 
the data from the Third Malaysian National Health Morbidity 
Survey (NHMS III) showed that the Indian ethnic group has 
the highest prevalence of diabetes mellitus compared with 
the other two major ethnic groups (19.9% versus 11.9% 
and 11.4% for Malay and Chinese groups respectively), 
and this inevitably contributed to their increased ACS risk.14 
Ramachandran et al has also demonstrated high incidence 
of glucose intolerance in Asian-Indian subjects with ACS, 
where 83.5% of the subjects either had diabetes or impaired 
glucose tolerance/impaired fasting glucose.15,16
Among the modifiable risk factors, as expected, we found the 
reproductive-aged women to have less comorbidities than older 
women, but nonsignificantly higher than the same-aged men. 
The presence of these risk factors may potentially negate the 
cardio-protectivity of estrogen against ACS.
Data from NHMS III found the national prevalence 
for hypertension is 32.2%, diabetes mellitus 11.6%, and 
dyslipidemia 7.1%. This is reflected in our study group, 
which shows hypertension to be the most common   comorbid 
  illness associated with ACS. With regards to diabetes 
mellitus, although the national prevalence was lower than 
hypertension, patients with ACS had higher prevalence 
compared with the general population (31.1 versus 11.6%), 
indicating the strong association of diabetes to ACS. 
  Similarly for dyslipidemia, reproductive-aged women with 
ACS recorded 24.4% prevalence compared with the national 
prevalence of 7.1%. It is of particular concern that females 
have significantly higher prevalence of hypercholesterolemia 
compared with males (8.0 versus 6.3%, respectively).
With regards to smoking, even though only 6.7% of the 
women in our study group smoked, compared with 84.1% 
of men, this rate is still higher than the national average 
Table 3 The Acs stratum
ACS stratum Study 
n = 45
Control 1 
n = 721
P value Control 2 
n = 454
P value
sTeMI 
(%)
23 
(51.1)
227 
(31.5) 
P = 0.0085 314 
(69.2) 
P = 0.0187
non-sTeMI 
(%)
9 
(20.0)
177 
(24.5)
58 
(12.8)
UA 
(%)
13 
(28.9)
317 
(44.0)
82 
(18.1)
Abbreviations: Acs, acute coronary syndrome; sTeMI, sT-elevation myocardial infarction; UA, unstable angina.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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for female smokers at 2.5%, indicating the importance 
of   smoking as a risk factor. Strong association between 
smoking and ACS has been repeatedly established, particu-
larly in younger patients.5,17 Milionis et al reported an odds 
ratio of 4.46 (95% confidence intervals [CI]: 2.30–8.66; 
P , 0.001) for smoking in 136 patients compared with age- 
and   sex-matched controls.17
Other than risk factors discussed above, reproductive-
aged women have at least two more additional risk   factors 
for ACS, namely the use of hormonal contraception 
and pregnancy. The use of oral contraceptive pills in 
reproductive-aged women has been shown to double the risk 
of ACS, while pregnancy increased it further to 3–4 times 
higher.2,4,18 In these patients the contribution of hypertension 
and diabetes to ACS were significant too.
Probably one the most important findings in this analysis 
is that reproductive-aged women recorded significantly more 
STEMI than non-STEMI when compared with older women, 
although still significantly less than same-aged men.
Overall, women are acknowledged to be less likely to 
present with STEMI than men. A large RCT, GUSTO IIb 
reported 27.2% STEMI in women versus 37.0% in men. 
However, in the subgroup of women who had STEMI, 
the age-adjusted prognosis was marginally worse than 
men with STEMI.17 In another analysis from a massive 
database that includes 1658 hospitals in the United States, 
the mortality rate among younger women with myocardial 
infarction is found to be significantly higher than men.18 
Therefore, it seems that while the prevalence of ACS in 
reproductive-aged women is low, for those with ACS, their 
prognosis is worse than older women or same-aged men, 
probably related to the higher incidence of STEMI in this 
group. It raises the question of whether younger women 
with ACS have some particularly strong risk factor, or lack 
of protective factor normally present in younger women 
without ACS. In this regard, variations in the estrogen-
regulated gene expressions and forms of estrogen recep-
tors, including the one with anti-estrogen effect, may be 
contributory.19 Early onset of ACS seems to be associated 
with the presence of combined risk factors. In this panel, 
we may include acquired common risk factors for ACS, in 
particular smoking and possibly gene variant associated to 
thrombotic disorders such as MTHFR C677T gene variant 
and ACE del\del genotype. However, further studies are 
needed to confirm this association.20
There are several limitations in our study. Firstly, the 
number of subjects in the study group was small, only 
45 out of a total of 9702 cases, and this has limited our 
ability to make a definitive conclusion. Also, being ret-
rospective, certain important data are not available for 
cross-analysis. Most notable is the mortality data that was 
not age and gender subcategorized. Therefore, although 
our study group has a higher prevalence of STEMI, we 
were unable to show that the actual mortality rate in this 
group is higher than the   controls due to this limitation. For 
similar reasons, we were also unable to stratify our analysis 
by ethnicity. While it would have been interesting to know 
how many of these patients are without risk factors, the 
database unfortunately did not age- and gender-specify the 
information and hence it is not available for discussion. 
Also, comparisons with the general population were made 
based on the available adult data across the age groups, 
and not age specific, hence limiting the significance of the 
comparisons. On the other hand, the NCVD is the most 
comprehensive available database on ACS, with data con-
tributed by all major hospitals in the country, and therefore 
is without doubt a good representation of the actual state 
of the disease in the country.
The findings from our analysis can be used in several 
ways. Most important is to recognize the high prevalence 
of risk factors in reproductive-aged women who develop 
ACS and that the cardio-protective effects of estrogen 
is somewhat negated by the strong association with the 
comorbidities. It is also important to realize that ACS in 
younger women   differs from older women where STEMI 
is more common and consequently mortality risk is higher. 
Although the   outcome and impact of current treatment strat-
egies are beyond the scope of this paper, the data presented 
should help to increase our awareness of the more likely 
nature of the ACS presenting in young women and would 
help strategize the management accordingly, possibly in 
regards to the urgency in commencing fibrinolytic therapy 
for this group.
Participating sites
The ACS database was piloted in 6 coronary care units 
(CCUs) on January 1, 2006. The CCUs were based in 
IJN, KL Hospital, University Malaya Medical Centre, 
Hospital Pulau Pinang, Hospital Sultanah Aminah, JB and 
  Hospital Umum Sarawak. One month later, following minor 
adjustments and review of the work-flow process, the Com-
puter Recovery Facility (CRF) was approved for nationwide 
use. Five Ministry of Health general hospitals around the 
country joined the 6 pilot centers. They are: Hospital Tuanku 
Fauziah Kangar, Perlis;   Hospital Tuanku Ja’afar Seremban, 
Negeri Sembilan; Hospital   Sultanah   Bahiyah Alor Setar, International Journal of Women’s Health
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Kedah; Hospital Raja   Perempuan Zainab II Kota Bahru, 
Kelantan; and H  ospital Tengku Ampuan Afzan Kuantan, 
Pahang. In addition, the medical department of Hospital 
Umum Sarawak also   participated. More hospitals have joined 
NCVD since 2006. They are: Ipoh Hospital, Perak; Queen 
Elizabeth Hospital, Sabah; Seberang Jaya Hospital; Hospital 
Sultanah Nur Zahirah, Terengganu; Hospital Tengku Ampuan 
Rahimah, Klang Selangor; and Hospital Besar Melaka.
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